StockData

ProPhase Labs, Inc. (PRPH) stock

PRPHOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 0/30
$0.01−0.00 (-6.16%)

Close on Oct 19, 2026Market cap $119.68KP/E –Yield –

ProPhase Labs price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

ProPhase Labs's price to sales ratio was 0.0× on Oct 19, 2026, against 2.6× a year earlier. Over the last 5 years it ranged from 0.0× to 3.3×, with a median of 1.4×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 20260.0×−0.3
2025Dec 31, 20250.4×−1.2
2024Dec 31, 20241.6×+0.3
2023Dec 29, 20231.3×+0.2
2022Dec 30, 20221.0×−1.8
2021Dec 31, 20212.8×−3.4
2020Dec 31, 20206.2×+4.3
2019Jan 31, 20191.9×−0.1
2018Dec 31, 20182.0×−2.2
2017Dec 29, 20174.2×+4.0
2016Jan 29, 20160.2×−0.0
2015Dec 31, 20150.3×−0.7
2014Jan 31, 20141.0×+0.2
2013Dec 31, 20130.8×–

More ProPhase Labs figures

See a number that looks wrong?